Clinical trial
A Novel Harm Reduction Approach for Oncology Outpatients Who Smoke and Refuse Traditional Tobacco Treatment
NCT07039292 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Harm Reduction Approach for Oncology Outpatients Who Smoke and Refuse Traditional Tobacco Treatment
- Lead sponsor
- Medical University of South Carolina
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- August 25, 2025
- Completion date
- November 30, 2029
- Enrollment
- 208 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
e-cig use, oncology, smoking